1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Jordan Schultz: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Terazosin for Parkinson's Disease Terazosin 5 MG, Placebo oral capsule - Parkinson Disease | Phase 1 / Phase 2 | Completed | Jordan Schultz | 13 | 2019-09-24 | 2022-05-16 |
| Neurobiological Predictors of Huntington's Disease (PREDICT-HD) Huntington Disease | Active not recruiting | Jordan Schultz | 1700 | 2002-08-01 | 2025-01-14 |
Huntington Disease (1) · Parkinson Disease (1)
Terazosin (1)
United States (2)
Jane S. Paulsen, Ph.D. (1) · Nandakumar Narayanan, MD, PhD (1)
PMID 26472629, PMID 29282329, PMID 30644132, PMID 41363816
R01NS040068 (1)